827P First Real-Life Data on Olaparib in 1st Line (1stl) Maintenance BRCA1/2 Mutated Epithelial Ovarian Cancer (EOC) in France: Descriptive Analysis of 201 Patients (pts) Enrolled in the Cohort Temporary Authorization for Use (Atuc)